期刊文献+

结核分枝杆菌调节蛋白RelA的原核表达及多克隆抗体制备 被引量:12

Preparation of polyclonal antibody and prokaryotic expression of recombinant protein RelA from Mycobacterium tuberculosis
下载PDF
导出
摘要 目的:克隆编码结核分枝杆菌调节基因RelA并在大肠杆菌中表达,纯化后制备兔抗RelA的抗体。方法:利用PCR从结核分枝杆菌H37Rv株中扩增RelA基因,构建重组表达质粒pET-32a(+)-RelA;以重组质粒转化大肠杆菌BL21(DE3),筛选阳性重组菌株,IPTG诱导目的蛋白表达,在变性条件下对目的蛋白进行镍离子亲和层析纯化,通过SDS-PAGE和Westem blot鉴定目的蛋白的表达及反应原性;以表达的RelA蛋白免疫家兔,制备抗RelA的多克隆抗体并进行效价及特异性鉴定。结果:扩增了RelA基因,克隆于表达载体pET-32a(+)中,PCR筛选和酶切鉴定获得阳性克隆,测序证实正确。经诱导在大肠杆菌中表达出相对分子质量(Mr)为120 000的目的蛋白;纯化的RelA免疫家兔后,能有效地刺激特异性抗体的产生,抗血清的效价达到1∶6 400以上,且具有良好的特异性。结论:已成功构建RelA基因的原核表达载体,并在大肠杆菌中获得高效表达;制备出兔抗RelA抗体,效价及特异性均良好,为进一步研究RelA蛋白在结核病中的致病机制奠定了基础。 AIM: To prepare polyclonal antibodies against RelA protein of Mycobacterium tuberculosis.METHODS: RelA gene segment was inserted into pET-32a(+) and the recombinant protein RelA was expressed in E.coli under IPTG induction.The protein was purified and identifed by SDS-PAGE and Western blot.Polyclonal antibody to RelA was got by immunizing rabbits with the protein.Quality and quantity of the antibody was identified.RESULTS: RelA gene segment was successfully inserted into pET-32a(+) and recombinant protein RelA was obtained.The polyclonal antibody to RelA had a good specificity,and the titer reached more than 1∶ 6 400.CONCLUSION: RelA recombinant protein and rabbit anti-RelA polyclonal antibody with high specificity were obtained,which provided good tools for further studying functional characterization of RelA.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第2期170-173,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30972639)
关键词 结核分枝杆菌 RELA 原核表达 多克隆抗体 Mycobaeterium tuberculosis RelA prokaryotic expression polyclonal antibody
  • 相关文献

参考文献9

  • 1Robert J Stewait, et al. Rapid Detection of Lactic Acid Bacteria in Fermenter Samples Using a Nested Polymerase Chain Reaction[J].Brew. Chem. 1996,(2): 78-84.
  • 2Sajish M,Kalayil S,Verma SK,et al.The significance of EXDD andRXKD motif conservation in Rel proteins[J].J Biol Chem,2009,284(14):9115-9123.
  • 3Jacqueline L, et al. Simpson[J]. Journal of Bacteriology. 1994, 635-638.
  • 4李娜,朱道银,帖儒修,王瑜伟.小鼠Ipr1基因与EGFP基因融合表达载体的构建及其在鼠巨噬细胞中的表达[J].细胞与分子免疫学杂志,2008,24(3):231-233. 被引量:5
  • 5Manabu Sami, H, et al. Of Fermentation And Bioengineering[J].Brew. Chem.,1997 ,(1):1-6.
  • 6Primm TP,Andersen SJ,Mizrahi V,et al.The stringent response ofMycobacterium tuberculosis is required for long-term survival[J].JBacteriol,2000,182(17):4889-4898.
  • 7Keiichi Goto. Reclassification of Brevibacillus Brevis[J]. Appl.Microbiol. 2000: 1-8.
  • 8Yu-Li Song, et al. Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR[J]. FEMS Microbiology Letters. 2000: 167-173.
  • 9J. Walter,G.W. Detection and Identification of Gastrointestinal Lactobacillus Species by Using Denaturing Gradient GelElectrophoresis and Species-Specific PCR Primers[J]. Applied And Environmental Microbiology,2000,(1): 297-303.

二级参考文献7

  • 1马玲娣,张彦,文世宏,何於娟,刘小珊,康格非,蒋纪恺.小鼠TIM2基因真核表达载体的构建及鉴定[J].细胞与分子免疫学杂志,2006,22(6):713-715. 被引量:2
  • 2[1]Bellamy R.Genetic susceptibility to tuberculosis[J].Clin Chest Med,2005,26(2):233-246.
  • 3[2]Pan H,Yan BS,Rojas M,et al.Ipr1 gene mediates innate immunity to Tuberculosis[J].Nature,2005,434(7034):767-772.
  • 4[4]Pieters J.Entry and survival of pathogenic mycobacteria in macrophage[J].Microbes Infect,2001,3(3):249-255.
  • 5[5]Fremond CM,Yeremeev V,Nicolle DM,et al.Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88[J].J Clin Invest,2004,114(12):405-412.
  • 6[6]Kramnik I,Dietrich WF,Demant P,et al.Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis[J].Proc Natl Acad Sci USA,2000,97(15):8560-8565.
  • 7[7]Stearns T.Green fluorescent protein.The green revolution[J].Curr Biol,1995,5(3):262-264.

共引文献5

同被引文献148

  • 1崔建和,杨士军,刘满庆.NSE、MMS、IL-8联检对良、恶性胸水的临床诊断价值[J].放射免疫学杂志,2005,18(3):169-171. 被引量:4
  • 2张步彩,叶亦见,Charles Muleke,李祥瑞.鸡球虫耐药性的研究进展[J].中国兽药杂志,2005,39(11):39-42. 被引量:9
  • 3吕素芳,刘峥,郭广君,蔡永萍,邱德文.大肠杆菌中表达外源重组蛋白的研究[J].科学技术与工程,2006,6(18):2872-2876. 被引量:14
  • 4Bast RC. Jr, Feeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma[ J]. J Clin Invest, 1981, 68 (5) : 1331 -1337.
  • 5Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene[ J]. Int J Cancer, 2002, 98 (5) : 737 - 740.
  • 6Scholler N, Urban N. CA125 in ovarian cancer[J]. Biomark Med, 2007, 1(4) : 513 -523.
  • 7O'Brien TJ, Beard JB, Underwood LJ, et al. The CA125 gene: an exla'aceUular superstructure dominated by repeat sequences[J]. Tumor Biol, 2001, 22(6) : 348 -366.
  • 8Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16 [J]. J Biol Chem, 2001, 276 (29) : 27371 -27375.
  • 9Randall LM, Sill MW, Burger RA, et al. Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a gynecologic oncology group phase II trial[J]. Gynecol Oncol, 2012, 124(3) : 563 - 568.
  • 10] Patankar MS, Jing Y, Morrison JC, et al. Potent suppression of natu- ral killer cell response mediated by the ovarian tumor marker CA125 [J], Gynecol Oncol, 2005, 99(3) : 704 -713.

引证文献12

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部